BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu M, Yang M, Zhang J, Yin Y, Fan X, Zhang Y, Qin S, Zhang H, Yu F. Immunogenic Cell Death Induction by Ionizing Radiation. Front Immunol 2021;12:705361. [PMID: 34489957 DOI: 10.3389/fimmu.2021.705361] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 27.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang R, Neighbors J, Schell T, Hohl R. Schweinfurthin induces ICD without ER stress and caspase activation. OncoImmunology 2022;11:2104551. [DOI: 10.1080/2162402x.2022.2104551] [Reference Citation Analysis]
2 Xie D, Wang Q, Wu G. Research progress in inducing immunogenic cell death of tumor cells. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1017400] [Reference Citation Analysis]
3 Ma G, Wang N, Bai X, Wang D, Ye J, Lu F, Ji C. An Immunogenic Cell Death-Based Risk model Predicts Prognosis and Indicates Immune Infiltration Landscape in Acute Myeloid Leukemia.. [DOI: 10.21203/rs.3.rs-2247524/v1] [Reference Citation Analysis]
4 Bai J, Wu B, Zhao S, Wang G, Su S, Lu B, Hu Y, Geng Y, Guo Z, Wan J, Ouyang W, Hu C, Liu J. The Effect of PD-1 Inhibitor Combined with Irradiation on HMGB1-Associated Inflammatory Cytokines and Myocardial Injury. JIR 2022;Volume 15:6357-6371. [DOI: 10.2147/jir.s384279] [Reference Citation Analysis]
5 Cao X, Zhou X, Chen C, Wang Z, Sun Q. Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.962389] [Reference Citation Analysis]
6 Kimm MA, Kästle S, Stechele MMR, Öcal E, Richter L, Ümütlü MR, Schinner R, Öcal O, Salvermoser L, Alunni-fabbroni M, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M. Early monocyte response following local ablation in hepatocellular carcinoma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.959987] [Reference Citation Analysis]
7 Zhang X, Zou N, Deng W, Song C, Yan K, Shen W, Zhu S. HMGB1 induces radioresistance through PI3K/AKT/ATM pathway in esophageal squamous cell carcinoma. Mol Biol Rep 2022. [PMID: 36260180 DOI: 10.1007/s11033-022-07989-8] [Reference Citation Analysis]
8 Bai Y, Zhang X, Zheng J, Liu Z, Yang Z, Zhang X. Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist. J Exp Clin Cancer Res 2022;41:302. [PMID: 36229853 DOI: 10.1186/s13046-022-02511-1] [Reference Citation Analysis]
9 Camero S, Cassandri M, Pomella S, Milazzo L, Vulcano F, Porrazzo A, Barillari G, Marchese C, Codenotti S, Tomaciello M, Rota R, Fanzani A, Megiorni F, Marampon F. Radioresistance in rhabdomyosarcomas: Much more than a question of dose. Front Oncol 2022;12:1016894. [DOI: 10.3389/fonc.2022.1016894] [Reference Citation Analysis]
10 Ren J, Yang J, Na S, Wang Y, Zhang L, Wang J, Liu J. Comprehensive characterisation of immunogenic cell death in melanoma revealing the association with prognosis and tumor immune microenvironment. Front Immunol 2022;13:998653. [DOI: 10.3389/fimmu.2022.998653] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Liu X, Kifle MT, Xie H, Xu L, Luo M, Li Y, Huang Z, Gong Y, Wu Y, Xie C. Biomineralized Manganese Oxide Nanoparticles Synergistically Relieve Tumor Hypoxia and Activate Immune Response with Radiotherapy in Non-Small Cell Lung Cancer. Nanomaterials (Basel) 2022;12:3138. [PMID: 36144927 DOI: 10.3390/nano12183138] [Reference Citation Analysis]
12 Pazzaglia S, Eidemüller M, Lumniczky K, Mancuso M, Ramadan R, Stolarczyk L, Moertl S. Out-of-field effects: lessons learned from partial body exposure. Radiat Environ Biophys 2022. [PMID: 36001144 DOI: 10.1007/s00411-022-00988-0] [Reference Citation Analysis]
13 Li Z, Chu Z, Yang J, Qian H, Xu J, Chen B, Tian T, Chen H, Xu Y, Wang F. Immunogenic Cell Death Augmented by Manganese Zinc Sulfide Nanoparticles for Metastatic Melanoma Immunotherapy. ACS Nano 2022. [PMID: 35981098 DOI: 10.1021/acsnano.2c08013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Liu M, Hao L, Zhao D, Li J, Lin Y. Self-Assembled Immunostimulatory Tetrahedral Framework Nucleic Acid Vehicles for Tumor Chemo-immunotherapy. ACS Appl Mater Interfaces 2022. [PMID: 35973112 DOI: 10.1021/acsami.2c09462] [Reference Citation Analysis]
15 Xie H, Liu X, Huang Z, Xu L, Bai R, He F, Wang M, Han L, Bao Z, Wu Y, Xie C, Gong Y. Nanoscale Zeolitic Imidazolate Framework (ZIF)–8 in Cancer Theranostics: Current Challenges and Prospects. Cancers 2022;14:3935. [DOI: 10.3390/cancers14163935] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Wang S, Wang Y, Jin K, Zhang B, Peng S, Nayak AK, Pang Z. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2108786] [Reference Citation Analysis]
17 Zhang S, Zhang J, Fan X, Liu H, Zhu M, Yang M, Zhang X, Zhang H, Yu F. Ionizing Radiation-Induced Ferroptosis Based on Nanomaterials. IJN 2022;Volume 17:3497-507. [DOI: 10.2147/ijn.s372947] [Reference Citation Analysis]
18 Zheng D, Hou X, Yu J, He X. Combinatorial Strategies With PD-1/PD-L1 Immune Checkpoint Blockade for Breast Cancer Therapy: Mechanisms and Clinical Outcomes. Front Pharmacol 2022;13:928369. [DOI: 10.3389/fphar.2022.928369] [Reference Citation Analysis]
19 Sengedorj A, Hader M, Frey B, Fietkau R, Ott OJ, Gaipl US, Rückert M. Interaction of Radiotherapy and Hyperthermia with the Immune System: a Brief Current Overview. Curr Stem Cell Rep. [DOI: 10.1007/s40778-022-00215-y] [Reference Citation Analysis]
20 Ji H, Zhou Z. A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy. Cancers 2022;14:3505. [DOI: 10.3390/cancers14143505] [Reference Citation Analysis]
21 Bao X, Xie L. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death. J Exp Clin Cancer Res 2022;41:222. [PMID: 35836249 DOI: 10.1186/s13046-022-02430-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Xiang K, Kalthoff C, Münch C, Jendrossek V, Matschke J. Accumulation of oncometabolite D-2-Hydroxyglutarate by SLC25A1 inhibition: A metabolic strategy for induction of HR-ness and radiosensitivity. Cell Death Dis 2022;13:641. [DOI: 10.1038/s41419-022-05098-9] [Reference Citation Analysis]
23 Lucia F, Geier M, Schick U, Bourbonne V. Narrative Review of Synergistics Effects of Combining Immunotherapy and Stereotactic Radiation Therapy. Biomedicines 2022;10:1414. [PMID: 35740435 DOI: 10.3390/biomedicines10061414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Lewis S, Dawson L, Barry A, Stanescu T, Mohamad I, Hosni A. Stereotactic body radiation therapy for hepatocellular carcinoma: from infancy to ongoing maturity. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100498] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Mothersill C, Seymour C. Low dose radiation mechanisms: The certainty of uncertainty. Mutat Res Genet Toxicol Environ Mutagen 2022;876-877:503451. [PMID: 35483782 DOI: 10.1016/j.mrgentox.2022.503451] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Liu B, Ji Q, Cheng Y, Liu M, Zhang B, Mei Q, Liu D, Zhou S. Biomimetic GBM-targeted drug delivery system boosting ferroptosis for immunotherapy of orthotopic drug-resistant GBM. J Nanobiotechnology 2022;20:161. [PMID: 35351131 DOI: 10.1186/s12951-022-01360-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Simon Davis DA, Atmosukarto II, Garrett J, Gosling K, Syed FM, Quah BJ. Irradiation immunity interactions. J Med Imaging Radiat Oncol 2022. [PMID: 35261190 DOI: 10.1111/1754-9485.13399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Xie SS, Deng Y, Guo SL, Li JQ, Zhou YC, Liao J, Wu DD, Lan WF. Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation. Sci Rep 2022;12:3056. [PMID: 35197507 DOI: 10.1038/s41598-022-06848-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
29 Chang Y, Chang PM, Li C, Chan M, Lee Y, Chen M, Hsiao M. Aldolase A and Phospholipase D1 Synergistically Resist Alkylating Agents and Radiation in Lung Cancer. Front Oncol 2022;11:811635. [DOI: 10.3389/fonc.2021.811635] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Tang L, Zhang A, Zhang Z, Zhao Q, Li J, Mei Y, Yin Y, Wang W. Multifunctional inorganic nanomaterials for cancer photoimmunotherapy. Cancer Commun (Lond) 2022;42:141-63. [PMID: 35001556 DOI: 10.1002/cac2.12255] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
31 Sato A, Kraynak J, Marciscano AE, Galluzzi L. Radiation therapy: An old dog learning new tricks. Radiation Oncology and Radiotherapy Part A 2022. [DOI: 10.1016/s0091-679x(22)00139-x] [Reference Citation Analysis]
32 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2022. [DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
33 Galassi C, Ruan Y, Sato A, Jiménez-cortegana C, Klapp V, Bloy N, Guilbaud E, Petroni G, Buqué A, Galluzzi L, Yamazaki T. RT-PCR-assisted quantification of type I IFN responses in irradiated cancer cells. Radiation Oncology and Radiotherapy Part A 2022. [DOI: 10.1016/bs.mcb.2022.05.005] [Reference Citation Analysis]
34 Bhat V, Pellizzari S, Allan AL, Wong E, Lock M, Brackstone M, Lohmann AE, Cescon DW, Parsyan A. Radiotherapy and radiosensitization in breast cancer: Molecular targets and clinical applications. Crit Rev Oncol Hematol 2021;169:103566. [PMID: 34890802 DOI: 10.1016/j.critrevonc.2021.103566] [Reference Citation Analysis]
35 Moon EJ, Petersson K, Olcina MM. The importance of hypoxia in radiotherapy for the immune response, metastatic potential and FLASH-RT. Int J Radiat Biol 2021;:1-13. [PMID: 34726575 DOI: 10.1080/09553002.2021.1988178] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]